Neurocrine Biosciences
Utility Patent Applications

Last updated:

List of all Neurocrine Biosciences patents 48 in total

Status Patent
Application
Utility: Methods for the Administration of Certain VMAT2 Inhibitors External link
Filling date: 6 Sep 2025 Issue date: 10 Feb 2022
Application
Utility: CRF1 RECEPTOR ANTAGONIST, PHARMACEUTICAL FORMULATIONS AND SOLID FORMS THEREOF FOR THE TREATMENT OF CONGENITAL ADRENAL HYPERPLASIA External link
Filling date: 6 Sep 2025 Issue date: 27 Jan 2022
Application
Utility: TREATMENT OF CONGENITAL ADRENAL HYPERPLASIA External link
Filling date: 6 Sep 2025 Issue date: 25 Nov 2021
Application
Utility: N-[2-(1 -BENZYLPIPERIDIN-4-YL)ETHYL]-4-(PYRAZIN-2-YL)-PIPERAZINE-1 -CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS MUSCARINIC RECEPTOR 4 (M4) ANTAGONISTS FOR TREATING NEUROLOGICAL DISEASES External link
Filling date: 6 Sep 2025 Issue date: 4 Nov 2021
Application
Utility: METHODS FOR THE ADMINISTRATION OF COMT INHIBITORS External link
Filling date: 6 Sep 2025 Issue date: 4 Nov 2021
Application
Utility: GONADOTROPIN-RELEASING HORMONE RECEPTOR ANTAGONISTS AND METHODS RELATING THERETO External link
Filling date: 6 Sep 2025 Issue date: 16 Sep 2021
Application
Utility: METHODS FOR THE ADMINISTRATION OF COMT INHIBITORS External link
Filling date: 6 Sep 2025 Issue date: 22 Jul 2021
Application
Utility: TREATMENT OF HYPERKINETIC MOVEMENT DISORDERS External link
Filling date: 6 Sep 2025 Issue date: 1 Jul 2021
Application
Utility: Methods for the Administration of Certain VMAT2 Inhibitors External link
Filling date: 6 Sep 2025 Issue date: 10 Jun 2021
Application
Utility: TREATMENT OF CONGENITAL ADRENAL HYPERPLASIA External link
Filling date: 6 Sep 2025 Issue date: 13 May 2021
Application
Utility: Use of Valbenazine for Treating Schizophrenia or Schizoaffective Disorder External link
Filling date: 6 Sep 2025 Issue date: 22 Apr 2021
Application
Utility: METHODS FOR THE ADMINISTRATION OF CERTAIN VMAT2 INHIBITORS External link
Filling date: 6 Sep 2025 Issue date: 25 Feb 2021
Application
Utility: Methods for the Administration of Certain VMAT2 Inhibitors External link
Filling date: 6 Sep 2025 Issue date: 18 Feb 2021
Application
Utility: Methods for the Administration of Certain VMAT2 Inhibitors External link
Filling date: 6 Sep 2025 Issue date: 11 Feb 2021
Application
Utility: High Dosage Valbenazine Formulation and Compositions, Methods, and Kits Related Thereto External link
Filling date: 6 Sep 2025 Issue date: 4 Feb 2021
Application
Utility: High Dosage Valbenazine Formulation and Compositions, Methods, and Kits Related Thereto External link
Filling date: 6 Sep 2025 Issue date: 4 Feb 2021
Application
Utility: Methods for the Administration of Certain VMAT2 Inhibitors External link
Filling date: 6 Sep 2025 Issue date: 4 Feb 2021
Application
Utility: Methods for the Administration of Certain VMAT2 Inhibitors External link
Filling date: 6 Sep 2025 Issue date: 24 Dec 2020
Application
Utility: SUBSTITUTED TRIAZOLES AND METHODS RELATING THERETO External link
Filling date: 6 Sep 2025 Issue date: 24 Dec 2020
Application
Utility: METHODS FOR THE ADMINISTRATION OF CERTAIN VMAT2 INHIBITORS External link
Filling date: 6 Sep 2025 Issue date: 19 Nov 2020
Application
Utility: SYNTHETIC METHODS FOR PREPARATION OF (S)-(2R,3R,11BR)-3-ISOBUTYL-9,10-DIMETHOXY-2,3,4,6,7,11B-HEXAHYDRO-1H-PYR- IDO[2,1,-A]lSOQUINOLIN-2-YL 2-AMINO-3-METHYLBUTANOATE DI(4-METHYLBENZENESULFONATE) External link
Filling date: 6 Sep 2025 Issue date: 5 Nov 2020
Application
Utility: SYNTHETIC METHODS FOR PREPARATION OF (S)-(2R,3R,11BR)-3-ISOBUTYL-9,10-DIMETHOXY-2,3,4,6,7,11B-HEXAHYDRO-1H-PYR- IDO[2,1,-A]lSOQUINOLIN-2-YL 2-AMINO-3-METHYLBUTANOATE DI(4-METHYLBENZENESULFONATE) External link
Filling date: 6 Sep 2025 Issue date: 5 Nov 2020
Application
Utility: SYNTHETIC METHODS FOR PREPARATION OF (S)-(2R,3R,11BR)-3-ISOBUTYL-9,10-DIMETHOXY-2,3,4,6,7,11B-HEXAHYDRO-1H-PYR- IDO[2,1,-A]lSOQUINOLIN-2-YL 2-AMINO-3-METHYLBUTANOATE DI(4-METHYLBENZENESULFONATE) External link
Filling date: 6 Sep 2025 Issue date: 5 Nov 2020
Application
Utility: SYNTHETIC METHODS FOR PREPARATION OF (S)-(2R,3R,11BR)-3-ISOBUTYL-9,10-DIMETHOXY-2,3,4,6,7,11B-HEXAHYDRO-1H-PYR- IDO[2,1,-A]lSOQUINOLIN-2-YL 2-AMINO-3-METHYLBUTANOATE DI(4-METHYLBENZENESULFONATE) External link
Filling date: 6 Sep 2025 Issue date: 5 Nov 2020
Application
Utility: VALBENAZINE SALTS AND POLYMORPHS THEREOF External link
Filling date: 6 Sep 2025 Issue date: 29 Oct 2020
Application
Utility: VALBENAZINE SALTS AND POLYMORPHS THEREOF External link
Filling date: 6 Sep 2025 Issue date: 29 Oct 2020
Application
Utility: VALBENAZINE SALTS AND POLYMORPHS THEREOF External link
Filling date: 6 Sep 2025 Issue date: 29 Oct 2020
Application
Utility: Methods for the Administration of Certain VMAT2 Inhibitors External link
Filling date: 6 Sep 2025 Issue date: 29 Oct 2020
Application
Utility: High Dosage Valbenazine Formulation and Compositions, Methods, and Kits Related Thereto External link
Filling date: 6 Sep 2025 Issue date: 3 Sep 2020
Application
Utility: Methods for the Administration of Certain VMAT2 Inhibitors External link
Filling date: 6 Sep 2025 Issue date: 27 Aug 2020
Application
Utility: Methods for the Administration of Certain VMAT2 Inhibitors External link
Filling date: 6 Sep 2025 Issue date: 27 Aug 2020
Application
Utility: Methods for the Administration of Certain VMAT2 Inhibitors External link
Filling date: 6 Sep 2025 Issue date: 27 Aug 2020
Application
Utility: Methods for the Administration of Certain VMAT2 Inhibitors External link
Filling date: 6 Sep 2025 Issue date: 27 Aug 2020
Application
Utility: Methods for the Administration of Certain VMAT2 Inhibitors External link
Filling date: 6 Sep 2025 Issue date: 27 Aug 2020
Application
Utility: [9,10-DIMETHOXY-3-(2-METHYLPROPYL)-1H,2H,3H,4H,6H,7H,11BH-PYRIDO-[2,1-A]IS- OQUINOLIN-2-YL]METHANOL AND COMPOUNDS, COMPOSITIONS AND METHODS RELATING THERETO External link
Filling date: 6 Sep 2025 Issue date: 20 Aug 2020
Application
Utility: PROCESSES FOR THE PREPARATION OF URACIL DERIVATIVES External link
Filling date: 6 Sep 2025 Issue date: 13 Aug 2020
Application
Utility: Methods for the Administration of Certain VMAT2 Inhibitors External link
Filling date: 6 Sep 2025 Issue date: 23 Jul 2020
Application
Utility: Pharmaceutical Compositions Comprising an Antipsychotic Drug and a VMAT2 Inhibitor and Uses Thereof External link
Filling date: 6 Sep 2025 Issue date: 2 Jul 2020
Application
Utility: SYNTHETIC METHODS FOR PREPARATION OF (S)-(2R,3R,11bR)-3-ISOBUTYL-9,10-DIMETHOXY-2,3,4,6,7,11b-HEXAHYDRO-1H-PYR- IDO[2,1-a]ISOQUINOLIN-2-YL 2-AMINO-3-METHYLBUTANOATE DI(4-METHYLBENZENESULFONATE) External link
Filling date: 6 Sep 2025 Issue date: 11 Jun 2020
Application
Utility: USE OF VALBENAZINE FOR TREATING LEVODOPA-INDUCED DYSKINESIA External link
Filling date: 6 Sep 2025 Issue date: 11 Jun 2020
Application
Utility: VMAT2 INHIBITOR COMPOUNDS AND COMPOSITIONS THEREOF External link
Filling date: 6 Sep 2025 Issue date: 30 Apr 2020
Application
Utility: TREATMENT OF HYPERKINETIC MOVEMENT DISORDERS External link
Filling date: 6 Sep 2025 Issue date: 2 Apr 2020
Application
Utility: GONADOTROPIN-RELEASING HORMONE RECEPTOR ANTAGONISTS AND METHODS RELATING THERETO External link
Filling date: 6 Sep 2025 Issue date: 26 Mar 2020
Application
Utility: Methods for the Administration of Certain VMAT2 Inhibitors External link
Filling date: 6 Sep 2025 Issue date: 26 Mar 2020
Application
Utility: Use of Valbenazine for Treating Schizophrenia or Schizoaffective Disorder External link
Filling date: 6 Sep 2025 Issue date: 12 Mar 2020
Application
Utility: Pharmaceutical Compositions Comprising an Antipsychotic Drug and a VMAT2 Inhibitor and Uses Thereof External link
Filling date: 6 Sep 2025 Issue date: 19 Dec 2019
Application
Utility: Methods for the Administration of Certain VMAT2 Inhibitors External link
Filling date: 6 Sep 2025 Issue date: 19 Dec 2019
Application
Utility: TREATMENT OF CONGENITAL ADRENAL HYPERPLASIA External link
Filling date: 6 Sep 2025 Issue date: 1 Aug 2019

Showing 1 to 48 of 48 patents.